ICUI - Company ID 0000883984
The table below shows ICU MEDICAL INC/DE's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B |
| Cost of revenue | $1.41B | $1.56B | $1.52B | $1.58B | $824.82M | $809.51M |
| Gross profit | $822.04M | $824.78M | $739.87M | $697.76M | $491.49M | $461.50M |
| R&D | $87.50M | $88.61M | $85.34M | $92.98M | $47.50M | $42.95M |
ICU MEDICAL INC/DE reported annual revenue of $2.23B for fiscal year 2025. That is down 6.3% from $2.38B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $379.37M (FY 2016) to $2.23B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $625.21M |
| $638.76M |
| $606.69M |
| $608.35M |
| $302.58M |
| $283.95M |
| Operating income | $42.83M | $42.96M | $22.82M | -$42.90M | $123.25M | $98.16M |
| Income tax | $2.44M | $51.68M | -$48.64M | -$40.12M | $20.05M | $10.62M |
| Net income | $732.00K | -$117.69M | -$29.66M | -$74.29M | $103.14M | $86.87M |
| EPS (diluted) | $0.03 | -$4.83 | -$1.23 | -$3.11 | $4.74 | $4.02 |